A Prognostic Nomogram for T3N0 Rectal Cancer After Total Mesorectal Excision to Help Select Patients for Adjuvant Therapy
BackgroundThe recurrence rate of T3N0 rectal cancer after total mesorectal excision (TME) is relatively low, meaning that not all patients need adjuvant therapy (AT) (radiotherapy, chemotherapy, or chemoradiotherapy).MethodsPatients diagnosed with pT3N0M0 rectal cancer after TME were analyzed using...
Enregistré dans:
Auteurs principaux: | Chao Zhang, Shutao Zhao, Xudong Wang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b09db2ccdab544f7aacd918f7ba68b14 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Results and Outcomes of Rectal Cancer Treatment in the Era of Adjuvant Chemoradiation
par: Ahmad Izadpanah, et autres
Publié: (2019) -
Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy
par: Silin Chen, et autres
Publié: (2021) -
Evaluation of the learning curve of transanal total mesorectal excision: single-centre experience
par: Mateusz Rubinkiewicz, et autres
Publié: (2019) -
Comparison of transanal versus laparoscopic total mesorectal excision in low rectal cancer
par: Seyed Vahid Hosseini, et autres
Publié: (2020) -
Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer
par: Yan J, et autres
Publié: (2021)